Bibliotecas PUC-SP - Busca Integrada

Contribution of the Tumor Microenvironment to Metabolic Changes Triggering Resistance of Multiple Myeloma to Proteasome Inhibitors

af Jonas Schwestermann, Andrej Besse, Christoph Driessen, Lenka Besse
Udgivet i Frontiers in Oncology (2022-05-01)

Complete hematological and major molecular response through treatment with low‐dose Interferon alpha 2a in high‐risk polycythemia vera patient: a case report

af Christoph Driessen, Christoph Noppen, Georg Boonen, Juergen Drewe
Udgivet i Clinical Case Reports (2021-10-01)

The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma

af Lenka Besse, Marianne Kraus, Andrej Besse, Christoph Driessen, Ignazio Tarantino
Udgivet i Scientific Reports (2023-03-01)

Mutant TP53 driving the Warburg Effect in Mantle Cell lymphoma

af Johannes Kliebhan, Andrej Besse, Kerstin Kampa‐Schittenhelm, Marcus Schittenhelm, Christoph Driessen
Udgivet i Clinical Case Reports (2022-10-01)

Nondestructive Electrochemical Identification of Lithium Plating in High-Energy Automotive Batteries

af Syed Muhammad Abbas, Christoph Drießen, Marvin Sprenger, Christian Ellersdorfer, Ilie Hanzu, Gregor Gstrein
Udgivet i ACS Omega (2025-03-01)

Novel Peptide-drug Conjugate Melflufen Efficiently Eradicates Bortezomib-resistant Multiple Myeloma Cells Including Tumor-initiating Myeloma Progenitor Cells

af Konstantin Byrgazov, Andrej Besse, Marianne Kraus, Ana Slipicevic, Fredrik Lehmann, Christoph Driessen, Lenka Besse
Udgivet i HemaSphere (2021-07-01)

Immunoproteasome Activity in Chronic Lymphocytic Leukemia as a Target of the Immunoproteasome-Selective Inhibitors

af Andrej Besse, Marianne Kraus, Max Mendez-Lopez, Elmer Maurits, Herman S. Overkleeft, Christoph Driessen, Lenka Besse
Udgivet i Cells (2022-03-01)

Lenalidomide in cancer cachexia: a randomized trial of an anticancer drug applied for anti‐cachexia

af David Blum, Caroline Hertler, Rolf Oberholzer, Susanne deWolf‐Linder, Markus Joerger, Christoph Driessen, Florian Strasser
Udgivet i JCSM Rapid Communications (2022-01-01)

Humoral and cellular BNT162b2 mRNA-based booster vaccine-induced immunity in patients with multiple myeloma and persistence of neutralising antibodies: results of a prospective sin...

af Tobias Silzle, Christian R. Kahlert, Werner C. Albrich, Susanne Nigg, Ruth Demmer Steingruber, Christoph Driessen, Stefanie Fischer
Udgivet i Swiss Medical Weekly (2023-06-01)

High Immunoproteasome Activity and sXBP1 in Pediatric Precursor B-ALL Predicts Sensitivity towards Proteasome Inhibitors

af Lenka Besse, Andrej Besse, Marianne Kraus, Elmer Maurits, Herman S. Overkleeft, Beat Bornhauser, Jean-Pierre Bourquin, Christoph Driessen
Udgivet i Cells (2021-10-01)

Acupuncture in chemotherapy-induced dysgeusia (AcuDysg): study protocol of a randomised controlled trial

af Jürgen Barth, Claudia M Witt, Stephanie Roll, Christine Huber, Linxin Zhang, Marc Schlaeppi, Twyla Müller, Petra Voiss, Christoph Driessen
Udgivet i BMJ Open (2023-03-01)

Intravascular Lymphoma Mimicking Cerebral Stroke: Report of Two Cases

af Thomas Hundsberger, Sergio Cogliatti, Gian-Reto Kleger, Christian Fretz, Anita Gähler, Mark Anliker, Jean-Yves Fournier, Roger von Moos, Barbara Tettenborn, Christoph Driessen
Udgivet i Case Reports in Neurology (2011-10-01)

Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma

af Nicola Amodio, Maria Eugenia Gallo Cantafio, Cirino Botta, Valter Agosti, Cinzia Federico, Daniele Caracciolo, Domenica Ronchetti, Marco Rossi, Christoph Driessen, Antonino Neri, Pierosandro Tagliaferri, Pierfrancesco Tassone
Udgivet i Cancers (2019-02-01)

A metabolic switch in proteasome inhibitor-resistant multiple myeloma ensures higher mitochondrial metabolism, protein folding and sphingomyelin synthesis

af Lenka Besse, Andrej Besse, Max Mendez-Lopez, Katerina Vasickova, Miroslava Sedlackova, Petr Vanhara, Marianne Kraus, Jürgen Bader, Renan B. Ferreira, Ronald K. Castellano, Brian K. Law, Christoph Driessen
Udgivet i Haematologica (2019-09-01)

Integrated phosphoproteomics and transcriptional classifiers reveal hidden RAS signaling dynamics in multiple myeloma

af Yu-Hsiu T. Lin, Gregory P. Way, Benjamin G. Barwick, Margarette C. Mariano, Makeba Marcoulis, Ian D. Ferguson, Christoph Driessen, Lawrence H. Boise, Casey S. Greene, Arun P. Wiita
Udgivet i Blood Advances (2019-11-01)

Combined inhibition of p97 and the proteasome causes lethal disruption of the secretory apparatus in multiple myeloma cells.

af Holger W Auner, Anne Marie Moody, Theresa H Ward, Marianne Kraus, Enrico Milan, Philippa May, Aristeidis Chaidos, Christoph Driessen, Simone Cenci, Francesco Dazzi, Amin Rahemtulla, Jane F Apperley, Anastasios Karadimitris, Niall Dillon
Udgivet i PLoS ONE (2013-01-01)

Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland

af Panagiotis Samaras, Mario Bargetzi, Daniel C. Betticher, Christoph Driessen, Michel A. Duchosal, Dominik Heim, Nicolas Ketterer, Erika Lerch, Thomas Matthes, Ulrich Mey, Thomas Pabst, Adrian Schmidt, Christian Taverna, Thilo Zander, Christoph Renner
Udgivet i Swiss Medical Weekly (2019-04-01)

Updated recommendations for diagnosis and treatment of multiple myeloma in Switzerland

af Martina Bertschinger, Holger W. Auner, Veronika Ballova, Carmen de Ramon Ortiz, Christoph Driessen, Sabine Gerull, Dominik Heim, Barbara Jeker, Erika Lerch, Rouven Müller, Thomas Pabst, Panagiotis Samaras, Adrian Schmidt, Christian Taverna, Thilo Zander, Ulrich Mey, Christoph Renner
Udgivet i Swiss Medical Weekly (2025-10-01)

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with...

af Christoph Driessen, Marianne Kraus, Markus Joerger, Hilde Rosing, Jürgen Bader, Felicitas Hitz, Catherine Berset, Alexandros Xyrafas, Hanne Hawle, Gregoire Berthod, Hermann S. Overkleeft, Christiana Sessa, Alwin Huitema, Thomas Pabst, Roger von Moos, Dagmar Hess, Ulrich J.M. Mey
Udgivet i Haematologica (2016-03-01)

The novel β2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cells

af Marianne Kraus, Juergen Bader, Paul P. Geurink, Emily S. Weyburne, Anne C. Mirabella, Tobias Silzle, Tamer B. Shabaneh, Wouter A. van der Linden, Gerjan de Bruin, Sarah R. Haile, Eva van Rooden, Christina Appenzeller, Nan Li, Alexei F. Kisselev, Herman Overkleeft, Christoph Driessen
Udgivet i Haematologica (2015-10-01)